-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-mellitus-screening-2003
February 01, 2003 - The differences in the timing of screening and the treatments in the study groups make it difficult to … Data on the effects of diet therapy alone for treating GDM are limited. … related to screening for GDM, including the costs of screening and diagnostic tests, costs of various treatments … Gestational diabetes mellitus (GDM) comparative evaluation of two treatment regimens, diet versus insulin … Emotional adjustment to diagnosis and intensified treatment of gestational diabetes.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
October 26, 2015 - The harms of drug therapy for the prevention of diabetes are small to moderate, depending on the drug … More U.S. data are also needed on the benefits and harms of lifestyle interventions and medical treatments … = 0.01). 25
Lipid-lowering therapy seemed to be similarly effective in RR reduction regardless of diabetes … Effects of combination lipid therapy in type 2 diabetes mellitus. … Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TjDzC7rzm3WzCDHFC4sJhQ
June 01, 2015 - More evidence is needed to
determine the effectiveness of treatments for screen-detected
diabetes. … Treatment of IFG or IGT was associated with delayed
progression to diabetes. … Treatment of IFG or IGT was associated with
delayed progression to diabetes. … Low-dose combination therapy with rosiglitazone
and metformin to prevent type 2 diabetes mellitus (CANOE … Impact of
intensive lifestyle and metformin therapy on cardiovascular disease
risk factors in the diabetes
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z7HXw3FPGLPFrcJoKq6ZeK
May 01, 2022 - asymptomatic celiac disease to improve
morbidity, mortality, or quality of life compared with no treatment … or treatment after clinical
diagnosis; and
• The harms of screening for or treatment of celiac disease … Long-term health and treatment outcomes in adult coeliac disease
patients diagnosed by screening in … Accuracy of Screening Tests for Celiac Disease in
Asymptomatic Patients With Type 1 Diabetes. … Screening and Treatment Outcomes in Adults and Children
With Type 1 Diabetes and Asymptomatic Celiac
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/u5uLCBoLdaf2pdNfQvEQYr
August 13, 2019 - For treatment, the population was
women with gestational diabetes or hyperglycemia. … Evaluating
the therapeutic approach in pregnancies
complicated by borderline glucose intolerance:
a randomized … Effect of treatment of gestational
diabetes mellitus on pregnancy outcomes. … A multicenter, randomized trial of
treatment for mild gestational diabetes. … Effect of treatment of mild
gestational diabetes on long-term maternal
outcomes.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TYPA75a_t7HaJeDhWqCJ9n
August 13, 2019 - For treatment, the population was
women with gestational diabetes or hyperglycemia. … Evaluating
the therapeutic approach in pregnancies
complicated by borderline glucose intolerance:
a randomized … Effect of treatment of gestational
diabetes mellitus on pregnancy outcomes. … A multicenter, randomized trial of
treatment for mild gestational diabetes. … Effect of treatment of mild
gestational diabetes on long-term maternal
outcomes.
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/type2-diabetes-children-adolescents-screening
July 30, 2020 - improve health outcomes compared with no intervention, usual care, or interventions with different treatment … improve health outcomes compared with no intervention, usual care, or interventions with different treatment … KQs 3b, 3c: No intervention, placebo, usual care (can include minimal intervention), different treatment … , harms from false-positive results, burden, inconvenience, depression, and unnecessary testing and treatment … KQ 4: Serious side effects from treatment, including gastrointestinal side effects, mortality, myocardial
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/prediabetes-type2-diabetes-children-adolescents-screening
July 30, 2020 - improve health outcomes compared with no intervention, usual care, or interventions with different treatment … improve health outcomes compared with no intervention, usual care, or interventions with different treatment … KQs 3b, 3c: No intervention, placebo, usual care (can include minimal intervention), different treatment … , harms from false-positive results, burden, inconvenience, depression, and unnecessary testing and treatment … KQ 4: Serious side effects from treatment, including gastrointestinal side effects, mortality, myocardial
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary11/asymptomatic-bacteriuria-in-adults-screening-2008
July 15, 2008 - with diabetes met inclusion criteria for this update. … After the initial round of therapy, significantly ( P < 0.001) more women in the placebo group continued … These findings suggest that screening and treatment for asymptomatic bacteriuria in women with diabetes … Manitoba Diabetes Urinary Tract Infection Study Group. … group
Treating asymptomatic bacteriuria in nonpregnant women with diabetes increased antibiotic use
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/RoC9VuSorM_LR7sTvLeFF2
July 01, 2008 - in nonpregnant women with diabetes met inclusion
criteria for this update. … group
Treating asymptomatic
bacteriuria in
nonpregnant
women with
diabetes increased
antibiotic use … After the initial round of therapy, significantly (P �
0.001) more women in the placebo group continued … These findings suggest that screening
and treatment for asymptomatic bacteriuria in women
with diabetes … Manitoba Diabetes Uri-
nary Tract Infection Study Group.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prediabetes-type2-diabetes-children-adolescents-screening
November 12, 2020 - improve health outcomes compared with no intervention, usual care, or interventions with different treatment … improve health outcomes compared with no intervention, usual care, or interventions with different treatment … type 2 diabetes). … KQs 3b, 3c: No intervention, placebo, usual care (can include minimal intervention), different treatment … KQ 4: Serious side effects from treatment, including gastrointestinal side effects, mortality, myocardial
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/gestational-diabetes-screening-draft-rec-bulletin.pdf
March 15, 2021 - The Task Force recommends providers screen their
pregnant patients for gestational diabetes at or after … and who do not have signs or symptoms of gestational diabetes. … This can lead to high blood sugar and, in some cases, the development of gestational
diabetes. … Treatment can reduce the risk of babies born with a high birth weight, C-sections,
birth injuries, and … However, more research is needed on the
benefits and harms of screening and treatment before 24 weeks
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review11/asymptomatic-bacteriuria-in-adults-screening-2008
July 15, 2008 - with diabetes met inclusion criteria for this update. … Eligible patients were nonpregnant women older than 16 years of age with diabetes, normal renal function … After the initial round of therapy, significantly ( P < 0.001) more women in the placebo group continued … These findings suggest that screening and treatment for asymptomatic bacteriuria in women with diabetes … Manitoba Diabetes Urinary Tract Infection Study Group.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
October 01, 2011 - Weight-loss treatment re-
duced diabetes incidence in participants with prediabetes. … Role of orlistat in the treatment of obese patients with type 2 diabetes. … Impact of intensive lifestyle and
metformin therapy on cardiovascular disease risk factors in the diabetes … Clinical
efficacy of orlistat therapy in overweight and obese patients with insulin-treated
type 2 diabetes … Behavioral and
pharmacologic therapies for obesity. Nat Rev Endocrinol. 2010;6:578-88.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cardiovascular/aspirin-to-prevent-cardiovascular-disease-and-cancer
April 11, 2016 - Diabetes
Available evidence does not clearly support the heterogeneity of aspirin's treatment effect … The 11 primary prevention studies are heterogeneous in terms of aspirin dose; duration of therapy; baseline … conclude that the cardiovascular-related benefits (that is, nonfatal MI) occur during the first 5 years of therapy … AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic … Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cardiovascular/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - Diabetes
Available evidence does not clearly support the heterogeneity of aspirin's treatment effect … The 11 primary prevention studies are heterogeneous in terms of aspirin dose; duration of therapy; baseline … conclude that the cardiovascular-related benefits (that is, nonfatal MI) occur during the first 5 years of therapy … AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic … Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-kidney-disease-screening
July 13, 2023 - CKD, or whether patients are eligible for evaluated treatments for reasons other than CKD (e.g., presence … of diabetes mellitus, hypertension, or dyslipidemia). … Sodium-glucose cotransporter-2 inhibitors
Glucagon-like peptide-1 agonist
Statins
Screening tests and treatments … vs. placebo, usual care, or no treatment
More intensive vs. less intensive treatment (management of … Guidelines on evaluation of kidney disease in persons with diabetes mellitus and hypertension already
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obesity-in-adults-interventions
March 31, 2016 - What health effects (i.e., mortality and incidence of cardiovascular disease, type 2 diabetes mellitus … of cardiovascular disease
Management of diabetes *
Treatment of cancer
Condition definition … loss/maintenance is part of disease management (e.g., osteoarthritis, known cardiovascular disease, diabetes … of type 2 diabetes (e.g., metformin, pramlintide, empagliflozin, albiglutide, dulaglutide, alogliptin … , exenatide)
Complementary and alternative treatments (e.g., acupuncture, mindfulness)
Dietary supplements
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/weight-loss-prevent-obesity-related-morbidity-mortality
May 18, 2023 - Healthy lifestyle counseling with no weight-related messages
Primary prevention of weight gain
Treatment … of cardiovascular disease
Management of diabetes *
Treatment of cancer
Population
Adults … combination:
Behavioral-based interventions (e.g., behavior modification, cognitive behavioral therapy … for weight management (e.g., lorcaserin hydrochloride or phentermine)
Complementary and alternative treatments … of diabetes is included in a separate USPSTF review and recommendation.
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/behavioral-counseling-interventions-promote-healthy-diet-physical-activity-weight-loss-prevent-cardiovascular-disease-adults
May 18, 2023 - Healthy lifestyle counseling with no weight-related messages
Primary prevention of weight gain
Treatment … of cardiovascular disease
Management of diabetes *
Treatment of cancer
Population
Adults … combination:
Behavioral-based interventions (e.g., behavior modification, cognitive behavioral therapy … for weight management (e.g., lorcaserin hydrochloride or phentermine)
Complementary and alternative treatments … of diabetes is included in a separate USPSTF review and recommendation.